Top Markets
Coin of the day
Xspray Pharma AB (publ) Xspray Pharma AB (publ)

Xspray Pharma AB (publ)

XSPRAY
Clasificación en acciones #24988
Xspray Pharma AB (publ), a pharmaceutical firm based in Solna, Sweden,... Xspray Pharma AB (publ), a pharmaceutical firm based in Solna, Sweden, specializes in developing protein kinase inhibitors for precise cancer treatments. Their current drug pipeline includes HyNap-Nilo, aimed at chronic myeloid leukemia; HyNap-Sora, which targets renal, liver, and several types of thyroid cancer; and HyNap-Dasa, intended for both chronic myeloid leukemia and acute lymphoblastic leukemia. Established in 2003, the company was formerly known as Xspray Microparticles AB until its name change to Xspray Pharma AB (publ) in 2017.
Precio por acción
$1.19
Capitalización bursátil
$56.35M
Cambio (1 día)
2.31%
Cambio (1 año)
-73.10%
País
SE
Comercio Xspray Pharma AB (publ) (XSPRAY)

Categoría

Ratio P/B de Xspray Pharma AB (publ) (XSPRAY)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Xspray Pharma AB (publ), el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Xspray Pharma AB (publ) desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH
3.7087 -
US